🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on the social media company, the service has removed problematic material and prohibited related hashtags and search suggestions. The company said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Research also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with images of slimming results, glowing reviews and step-by-step guides for mixing or injecting at home.

After minutes of entering one community, a seller shared contact information, where most purchases take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Information and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially significant health risks”.